EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Progress in Precision Medicine for Head and Neck Cancer

Sanaz Vakili, Amir Barzegar Behrooz iD, Rachel Whichelo iD, Alexandra Fernandes, Abdul-Hamid Emwas iD, Mariusz Jaremko, Jarosław Markowski iD, Marek J Los iD, Saeid Ghavami iD, Rui Vitorino iD

Cancers · 04.11.2024 · 16 (21) · 3716

DOI: 10.3390/cancers16213716 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 04.11.2024. Verfasst von Sanaz Vakili und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Anatomy and Cell Science, University of Manitoba College of Medicine, Winnipeg, MB R3E 0J9, Canada. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FCT—Portuguese Foundation for Science and Technology, Cardiovascular R&D Center—UnIC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper presents a comprehensive comparative analysis of biomarkers for head and neck cancer (HNC), a prevalent but molecularly diverse malignancy. We detail the roles of key proteins and genes in tumourigenesis and progression, emphasizing their diagnostic, prognostic, and therapeutic relevance. Our bioinformatic validation reveals crucial genes such as AURKA, HMGA2, MMP1, PLAU, and SERPINE1, along with microRNAs (miRNA), linked to HNC progression. OncomiRs, including hsa-miR-21-5p, hsa-miR-31-5p, hsa-miR-221-3p, hsa-miR-222-3p, hsa-miR-196a-5p, and hsa-miR-200c-3p, drive tumourigenesis, while tumour-suppressive miRNAs like hsa-miR-375 and hsa-miR-145-5p inhibit it. Notably, hsa-miR-155-3p correlates with survival outcomes in addition to the genes RAI14, S1PR5, OSBPL10, and METTL6, highlighting its prognostic potential. Future directions should focus on leveraging precision medicine, novel therapeutics, and AI integration to advance personalized treatment strategies to optimize patient outcomes in HNC care.

Schlagwörter

Stichwörter der Autor:innen

biomarkersgenetic alterationshead and neck cancerprecision medicinetargeted therapy

Autor:innen und Institutionen

  • Department of Human Anatomy and Cell Science, University of Manitoba College of Medicine, Winnipeg, MB R3E 0J9, Canada.
  • Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, 3810-193 Aveiro, Portugal.
  • Guelph College of Biological Science, University of Guelph, Guelph, ON N1G 2W1, Canada.
  • Core Lab of NMR, King Abdullah University of Science and Technology (KAUST), Thuwal, Makkah 23955-6900, Saudi Arabia.
  • Division of Biological and Environmental Sciences and Engineering (BESE), King Abdullah University of Science and Technology (KAUST), Thuwal, Makkah 23955-6900, Saudi Arabia.
  • Department of Laryngology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-027 Katowice, Poland.

ORCID-Profile: Amir Barzegar Behrooz, Rachel Whichelo, Abdul-Hamid Emwas, Jarosław Markowski, Marek J Los, Saeid Ghavami, Rui Vitorino

Förderung

  • FCT—Portuguese Foundation for Science and Technology
  • Cardiovascular R&D Center—UnIC

Zitieren

APA

Vakili, S., Behrooz, A. B., Whichelo, R., Fernandes, A., Emwas, A. H., Jaremko, M., Markowski, J., Los, M. J., Ghavami, S., & Vitorino, R. (2024). Progress in Precision Medicine for Head and Neck Cancer. Cancers, 16(21), 3716. https://doi.org/10.3390/cancers16213716

Vancouver

Vakili S, Behrooz AB, Whichelo R, Fernandes A, Emwas AH, Jaremko M, et al. Progress in Precision Medicine for Head and Neck Cancer. Cancers. 2024;16(21):3716. doi:10.3390/cancers16213716

BibTeX
@article{Vakili2024,
  author = {Vakili, Sanaz and Behrooz, Amir Barzegar and Whichelo, Rachel and Fernandes, Alexandra and Emwas, Abdul-Hamid and Jaremko, Mariusz and Markowski, Jarosław and Los, Marek J and Ghavami, Saeid and Vitorino, Rui},
  title = {Progress in Precision Medicine for Head and Neck Cancer},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {21},
  pages = {3716},
  doi = {10.3390/cancers16213716}
}
Kostenlos starten →